Henry Schein Extends Private Placement Facilities to 2028

Henry Schein ( (HSIC) ) has shared an announcement.

On December 19, 2025, Henry Schein, Inc. amended multiple existing private placement shelf facilities with institutional investors including Prudential, New York Life, MetLife, and Corebridge to extend their scheduled facility termination dates from prior maturities to December 19, 2028 and to adjust certain financial definitions and covenants. These amendments are designed to preserve and extend the company’s access to long-term private financing, supporting balance sheet flexibility and potentially strengthening its funding position within the health care products distribution sector, with implications for the stability and predictability of its capital structure for lenders and other stakeholders.

The most recent analyst rating on (HSIC) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Henry Schein stock, see the HSIC Stock Forecast page.

Spark’s Take on HSIC Stock

According to Spark, TipRanks’ AI Analyst, HSIC is a Outperform.

Henry Schein’s overall stock score reflects strong earnings call insights and positive technical indicators, offset by moderate financial performance and valuation concerns. The company’s strategic initiatives and share repurchase program bolster confidence, while increased leverage and cash conversion efficiency remain areas to watch.

To see Spark’s full report on HSIC stock, click here.

More about Henry Schein

Henry Schein, Inc. operates in the health care products and services industry, supplying medical, dental, and veterinary practitioners with a range of clinical and practice-management solutions, and uses private placement shelf facilities as part of its long-term financing strategy.

Average Trading Volume: 1,449,599

Technical Sentiment Signal: Strong Buy

Current Market Cap: $9.11B

For a thorough assessment of HSIC stock, go to TipRanks’ Stock Analysis page.